Literature DB >> 29530994

Establishment of a Multiplex PCR-Based Procedure for Detection of Most Common Mutations in NPM1, FLT3 in Acute Myeloid Leukemia Patients.

Phuong L Trinh1, Yen Pham2.   

Abstract

Numerous studies have identified Nucleophosmin 1 (NPM1) and Fms-like tyrosine kinase 3 (FLT3) as the most frequently mutated genes in Acute Myeloid Leukemia (AML) patients. Mutations occurring in these genes, including NPM1+4 (tetranucleotide insertions), FLT3-ITD (internal tandem duplications), and FLT3-TKD (tyrosine kinase domain point mutations) account for approximately 80% of all mutations found in normal karyotype AML (AML-NK) cases. Different methods have been established to detect the three listed mutations, in which, PCR-based techniques are the most widely used due to their efficiency. Past researches on performing multiplex PCR for simultaneous screening were successful for only two out of the three mutations of interest. In this study, from genomic DNA, we amplified three fragments corresponding to the regions containing these mutations in a single PCR reaction, digested the products with EcoRV, and then analyzed the migration pattern using 3% Ultraphor™ agarose electrophoresis. In case of wild types, the results showed three and four distinct bands before and after restriction enzyme treatment, respectively; and in case of mutants, the presence of extra bands indicated suspected length mutations. This method was used to screen 20 samples, identifying a total of 6 possible mutants, including 3 NPM1+4 and 3 FLT3-ITDs, which were verified through established procedures and capillary electrophoresis.
© 2018 by the Association of Clinical Scientists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29530994

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Development of a highly sensitive method for detection of FLT3D835Y.

Authors:  Yao Guo; Honghua Sun; Dengyang Zhang; Yuming Zhao; Mingxia Shi; Ming Yang; Shu Xing; Xueqi Fu; Ting Bin; Bo Lu; Shunjie Wu; Xiaojun Xu; Xuesong Xu; Yun Chen; Zhizhuang Joe Zhao
Journal:  Biomark Res       Date:  2020-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.